ILMN
73
4
VFC
70
2
EMR
64
5
NOV
52
4
OXY
40
2
INTU
60
-3
WYNN
50
2
MAR
71
3
IRM
41
10
AON
62
-5
STT
62
3
NOC
54
6
DGX
35
2
MMM
56
2
TEL
66
6
CTAS
40
-2
BAX
38
-12
NWSA
64
-15
TRIP
49
2
REGN
59
2
ILMN
73
4
VFC
70
2
EMR
64
5
NOV
52
4
OXY
40
2
INTU
60
-3
WYNN
50
2
MAR
71
3
IRM
41
10
AON
62
-5
STT
62
3
NOC
54
6
DGX
35
2
MMM
56
2
TEL
66
6
CTAS
40
-2
BAX
38
-12
NWSA
64
-15
TRIP
49
2
REGN
59
2
Financhill
Back

Entrada Therapeutics, Inc. Vs. Nebius Group NV Industry Stock Comparison

Buy
54

TRDA
Entrada Therapeutics, Inc.

Last Price:
$10.96
Seasonality Move:
-39.89%
Sell
42

NBIS
Nebius Group NV

Last Price:
$89.47
Seasonality Move:
-2.57%
Buy
54
Entrada Therapeutics, Inc. (TRDA) is a Buy

Is Entrada Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Entrada Therapeutics, Inc. [TRDA] share price is $10.98. The Score for TRDA is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
  • TRDA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
Nebius Group NV (NBIS) is a Sell

Is Nebius Group NV a Buy, Sell or Hold?

  • The current Nebius Group NV [NBIS] share price is $89.46. The Score for NBIS is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • NBIS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TRDA Stock Price Chart

What is Entrada Therapeutics, Inc.'s stock price today?

  • The Entrada Therapeutics, Inc. share price today is $10.98
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRDA is experiencing slight buying pressure.

NBIS Stock Price Chart

What is Nebius Group NV's stock price today?

  • The Nebius Group NV share price today is $89.46
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBIS is experiencing buying pressure, which is a positive indicator for future bullish movement.

TRDA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.07 Buy
Relative Strength Index (14 RSI): 66.81 Buy
Chaikin Money Flow: 12057 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (9.35 - 11.01) Buy
Bollinger Bands (100): (5.02 - 9) Buy

NBIS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -5.05 Sell
Relative Strength Index (14 RSI): 47.32 Sell
Chaikin Money Flow: 13904832 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (83.34 - 98.02) Sell
Bollinger Bands (100): (72.32 - 115.66) Sell

TRDA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 11.01 Sell
20-day SMA: 10.52 Buy
50-day SMA: 8.48 Buy
200-day SMA: 7.59 Buy
8-day EMA: 5.84 Buy
20-day EMA: 2.86 Buy
50-day EMA: 1.25 Buy
200-day EMA: 0.33 Buy

NBIS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 85.08 Buy
20-day SMA: 91.37 Sell
50-day SMA: 102.98 Sell
200-day SMA: 65.21 Buy
8-day EMA: 85.42 Buy
20-day EMA: 90.53 Sell
50-day EMA: 95.55 Sell
200-day EMA: 73.6 Buy

Entrada Therapeutics, Inc. Earnings Growth & TRDA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.44 per share, and a decrease next year of $0.64 per share.

Nebius Group NV Earnings Growth & NBIS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.56 per share.

Entrada Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nebius Group NV Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):